Should I buy or sell Zepp Health stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zepp Health in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ZEPP shares. View ZEPP analyst ratings or view top-rated stocks .

What is Zepp Health's stock price target for 2024?

1 Wall Street research analysts have issued twelve-month target prices for Zepp Health's stock. Their ZEPP share price targets range from $4.96 to $4.96. On average, they anticipate the company's stock price to reach $4.96 in the next year. This suggests a possible upside of 500.8% from the stock's current price. View analysts price targets for ZEPP or view top-rated stocks among Wall Street analysts .

How have ZEPP shares performed in 2024?

Zepp Health's stock was trading at $1.42 on January 1st, 2024. Since then, ZEPP shares have decreased by 41.9% and is now trading at $0.8256. View the best growth stocks for 2024 here .

Are investors shorting Zepp Health?

Zepp Health saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 52,900 shares, an increase of 2,304.5% from the March 15th total of 2,200 shares. Based on an average daily volume of 73,600 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.2% of the company's stock are short sold. View Zepp Health's Short Interest .

When is Zepp Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024. View our ZEPP earnings forecast .

How were Zepp Health's earnings last quarter?

Zepp Health Co. (NYSE:ZEPP) announced its quarterly earnings data on Monday, March, 18th. The company reported ($0.02) earnings per share for the quarter. The company earned $84.47 million during the quarter. Zepp Health had a negative trailing twelve-month return on equity of 8.55% and a negative net margin of 8.66%.

Is Zepp Health a good dividend stock?

Zepp Health (NYSE:ZEPP) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%. Read our dividend analysis for ZEPP .

What guidance has Zepp Health issued on next quarter's earnings?

Zepp Health updated its first quarter 2024 earnings guidance on Monday, March, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $42.0 million-$49.0 million, compared to the consensus revenue estimate of $72.6 million.

How do I buy shares of Zepp Health?

Shares of ZEPP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:ZEPP

Zepp Health (ZEPP) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free ZEPP Stock Alerts

$0.83

-0.02 (-2.37%)

(As of 04/17/2024 ET)

Compare

Today's Range: $0.82
▼
$0.85
50-Day Range: $0.83
▼
$1.38
52-Week Range: $0.82
▼
$2.10

Volume: 72,022 shs
Average Volume: 72,659 shs
Market Capitalization: $50.64 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.96

Get Zepp Health alerts:

Zepp Health MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 500.8% Upside
$4.96 Price Target
Short Interest: Healthy
0.17% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.40 out of 5 stars

Computer And Technology Sector

352nd out of 591 stocks

Consumer Electronics Industry

1st out of 1 stocks

3.5

Analyst's Opinion

Consensus Rating
Zepp Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Zepp Health has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.17% of the float of Zepp Health has been sold short.
Short Interest Ratio / Days to Cover
Zepp Health has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Zepp Health has recently increased by 2,304.55%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Zepp Health does not currently pay a dividend.
Dividend Growth
Zepp Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ZEPP.

2.0

News and Social Media Coverage

News Sentiment
Zepp Health has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Computer and Technology companies.
News Coverage This Week
MarketBeat has tracked 1 news article for Zepp Health this week, compared to 1 article on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Zepp Health insiders have not sold or bought any company stock.
Percentage Held by Insiders
36.00% of the stock of Zepp Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
52.61% of the stock of Zepp Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Zepp Health is -1.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Zepp Health is -1.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Zepp Health has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Zepp Health Stock (NYSE:ZEPP)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. It operates through two segments, Self-Branded Products and Others and Xiaomi Wearable Products. The company offers smart bands, watches, and scales; and associated accessories, smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

ZEPP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ZEPP Stock News Headlines

April 11, 2024 | msn.com

Kelvin Kiptum: International Firm Designs Trophy to Award Athlete's Family in Rotterdam Marathon

March 28, 2024 | msn.com

Xiaomi’s Smart Band 8 Pro is a cheap and easy way to track health, control media and get notifications in an Apple Watch-style design

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 27, 2024 | prnewswire.com

Zepp Health to Honor Marathon Icon Kelvin Kiptum with Amazfit Cheetah Pro Commemorative Edition Watch and Foundation Support

March 24, 2024 | uk.finance.yahoo.com

Zepp Health Full Year 2023 Earnings: Misses Expectations

March 20, 2024 | seekingalpha.com

Zepp Health Corporation (ZEPP) Q4 2023 Earnings Call Transcript

March 20, 2024 | investing.com

Zepp Health earnings missed by ¥1.34, revenue fell short of estimates

March 19, 2024 | finance.yahoo.com

Q4 2023 Zepp Health Corp Earnings Call

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 19, 2024 | seekingalpha.com

OTRK, STRC and APM among mid-day movers

March 19, 2024 | finance.yahoo.com

Zepp Health Corporation (NYSE:ZEPP) Q4 2023 Earnings Call Transcript

March 19, 2024 | finanznachrichten.de

Zepp Health Corp.: Zepp Health Corporation Reports Fourth Quarter and Full Year 2023 Unaudited Financial Results

March 18, 2024 | investorplace.com

ZEPP Stock Earnings: Zepp Health Misses EPS, Misses Revenue for Q4 2023

March 18, 2024 | benzinga.com

Recap: Zepp Health Q4 Earnings

March 18, 2024 | prnewswire.com

Zepp Health Corporation Reports Fourth Quarter and Full Year 2023 Unaudited Financial Results

March 15, 2024 | benzinga.com

A Preview Of Zepp Health's Earnings

March 9, 2024 | investing.com

Zepp Health Corp (ZEPP)

March 7, 2024 | finance.yahoo.com

Zepp Health Corporation to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024

March 1, 2024 | msn.com

Makers of Amazfit smartwatches introduce new over the counter hearing aids

February 26, 2024 | msn.com

Zepp Health launches Zepp OS 3.5 with AI-powered Zepp Flow

February 25, 2024 | prnewswire.com

Zepp Health Unveils Zepp OS 3.5 with Zepp Flow™, Powered by Large Language Model AI, Pioneering the Next Generation of Wearable Intelligence Devices at MWC Barcelona 2024

February 25, 2024 | benzinga.com

Zepp Health Stock (NYSE:ZEPP), Short Interest Report

February 23, 2024 | msn.com

Amazfit Active Edge Rugged Smartwatch Launched: Specifications, Price, Colours

February 17, 2024 | finance.yahoo.com

ZEPP Sep 2024 5.000 call

February 17, 2024 | finance.yahoo.com

ZEPP Jun 2024 2.500 put

February 6, 2024 | msn.com

This software update gives your Amazfit watch new AI-powered voice controls

February 5, 2024 | msn.com

Best smartwatches for fitness in 2024

See More Headlines

Receive ZEPP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zepp Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/18/2024
Today: 4/17/2024
Next Earnings (Estimated): 5/28/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Electronic computers
Sub-Industry: N/A
Current Symbol: NYSE:ZEPP
CUSIP: N/A
CIK: 1720446
Web: www.huami.com
Phone: 861059403268
Fax: N/A
Employees: 987
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $4.96
High Stock Price Target: $4.96
Low Stock Price Target: $4.96
Potential Upside/Downside: +500.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.49)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-29,880,000.00
Net Margins: -8.66%
Pretax Margin: -9.49%
Return on Equity: -8.55%
Return on Assets: -4.51%

Debt

Debt-to-Equity Ratio: 0.34
Current Ratio: 2.04
Quick Ratio: 1.49

Sales & Book Value

Annual Sales: $2.97 billion
Price / Sales: 0.02
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $5.75 per share
Price / Book: 0.14

Miscellaneous

Outstanding Shares: 61,335,000
Free Float: 39,254,000
Market Cap: $50.64 million
Optionable: Optionable
Beta: 0.81

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Wang Huang (Age 48)
Founder, Chairman & CEO
Mr. Mike Yan Yeung (Age 53)
COO & CFO
Mr. Leon Cheng Deng (Age 40)
Chief Financial Officer
Mr. Meihui Fan (Age 45)
Chief Technology Officer
Ms. Grace Yujia Zhang
Director of Investor Relations
Mr. Pengtao Yu (Age 42)
Chief Industrial Designer
Dr. Ramesh Jain Ph.D.
Chief Technical Advisor of Huami AI Research Institute

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

ZEPP Stock Analysis - Frequently Asked Questions

Should I buy or sell Zepp Health stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zepp Health in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ZEPP shares.
View ZEPP analyst ratings or view top-rated stocks.
What is Zepp Health's stock price target for 2024?: 1 Wall Street research analysts have issued twelve-month target prices for Zepp Health's stock. Their ZEPP share price targets range from $4.96 to $4.96. On average, they anticipate the company's stock price to reach $4.96 in the next year. This suggests a possible upside of 500.8% from the stock's current price.
View analysts price targets for ZEPP or view top-rated stocks among Wall Street analysts.
How have ZEPP shares performed in 2024?: Zepp Health's stock was trading at $1.42 on January 1st, 2024. Since then, ZEPP shares have decreased by 41.9% and is now trading at $0.8256.
View the best growth stocks for 2024 here.
Are investors shorting Zepp Health?: Zepp Health saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 52,900 shares, an increase of 2,304.5% from the March 15th total of 2,200 shares. Based on an average daily volume of 73,600 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.2% of the company's stock are short sold.
View Zepp Health's Short Interest.
When is Zepp Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024.
View our ZEPP earnings forecast.

How were Zepp Health's earnings last quarter?: Zepp Health Co. (NYSE:ZEPP) announced its quarterly earnings data on Monday, March, 18th. The company reported ($0.02) earnings per share for the quarter. The company earned $84.47 million during the quarter. Zepp Health had a negative trailing twelve-month return on equity of 8.55% and a negative net margin of 8.66%.
Is Zepp Health a good dividend stock?: Zepp Health (NYSE:ZEPP) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.00%.
Read our dividend analysis for ZEPP.
What guidance has Zepp Health issued on next quarter's earnings?: Zepp Health updated its first quarter 2024 earnings guidance on Monday, March, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $42.0 million-$49.0 million, compared to the consensus revenue estimate of $72.6 million.
How do I buy shares of Zepp Health?: Shares of ZEPP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ZEPP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial